176 related articles for article (PubMed ID: 227234)
1. Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome.
Oberg K; Boström H; Fahrenkrug J; Dymling JF; Shaffalitsky de Muckadell OB; Lundqvist G
Acta Med Scand; 1979; 206(3):223-7. PubMed ID: 227234
[TBL] [Abstract][Full Text] [Related]
2. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
Fahrenkrug J; Schaffalitzky de Muckadell OB
Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic islet cell carcinoma with gastrin and vasoactive intestinal polypeptide production.
Barragry TP; Wick MR; Delaney JP
Arch Surg; 1985 Oct; 120(10):1178-81. PubMed ID: 2994597
[TBL] [Abstract][Full Text] [Related]
4. Streptozotocin treatment in pancreatic cholera (Verner-Morrison) syndrome.
Pignal F; René E; Chayvialle JA; Rigaud D; Lehy T; Bonfils S
Digestion; 1982; 24(3):176-82. PubMed ID: 6292031
[TBL] [Abstract][Full Text] [Related]
5. Streptozotocin treatment of a juvenile onset type diabetic patient with Verner-Morrison syndrome and multi hormonal probable malignant islet cell carcinoma with liver metastases.
Granuci P; Mahler RJ
Horm Metab Res; 1982 Jun; 14(6):327-8. PubMed ID: 6288539
[No Abstract] [Full Text] [Related]
6. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
[TBL] [Abstract][Full Text] [Related]
7. Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma.
Devine BL; Carmichael HA; Russell RI; Joffe SN
Postgrad Med J; 1978 Aug; 54(634):566-70. PubMed ID: 215990
[TBL] [Abstract][Full Text] [Related]
8. Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.
Gagel RF; Costanza ME; DeLellis RA; Norton RA; Bloom SR; Miller HH; Ucci A; Nathanson L
Arch Intern Med; 1976 Dec; 136(12):1429-35. PubMed ID: 187136
[TBL] [Abstract][Full Text] [Related]
9. [The vaso-active intestinal polypeptide in Verner-Morrison syndrome].
Seif FJ; Sadowski P; Heni F; Fischer R; Bloom SR; Polak JM
Dtsch Med Wochenschr; 1975 Feb; 100(9):399-405. PubMed ID: 163727
[TBL] [Abstract][Full Text] [Related]
10. A pancreatic-polypeptide-producing tumour associated with the WDHA syndrome.
Lundqvist G; Krause U; Larsson LI; Grimelius L; Schaffalitzky de Muckadell OB; Fahrenkrug J; Johnson M; Chance RE
Scand J Gastroenterol; 1978; 13(6):715-8. PubMed ID: 151327
[TBL] [Abstract][Full Text] [Related]
11. VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.
Bloom SR; Polak JM
Clin Endocrinol (Oxf); 1976; 5 Suppl():223S-228S. PubMed ID: 212228
[TBL] [Abstract][Full Text] [Related]
12. Clinical and hormonal aspects of the watery diarrhea-hypokalemia-achlorhydria (WDHA) syndrome due to vasoactive intestinal polypeptide (VIP)-producing tumor.
Yamaguchi K; Abe K; Adachi I; Tanaka M; Ueda M; Oka Y; Miyakawa S; Kameya T; Yanaihara N
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():79-86. PubMed ID: 7014208
[TBL] [Abstract][Full Text] [Related]
13. [Vasoactive intestinal polypeptide in digestive processes in the Verner Morrison syndrome].
Leonardi R; Toffoli C; Rigamonti L; Rigamonti D; Gambassi G; Greco A; Ghirlanda G
Minerva Med; 1981 Jun; 72(26):1707-11. PubMed ID: 6265832
[TBL] [Abstract][Full Text] [Related]
14. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
Meuwese-Arends MT; Yap SH; Van Tongeren JH
Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
[No Abstract] [Full Text] [Related]
15. [Hormones of the digestive system. II. Pathology].
Vigouroux N; Thomas M
Med Chir Dig; 1978; 7(4):289-302. PubMed ID: 209259
[No Abstract] [Full Text] [Related]
16. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
Rehfeld JF
Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin].
Várkonyi TT; Velösy B; Nagy I; Németh J; Lonovics J
Orv Hetil; 1993 Nov; 134(47):2599-602. PubMed ID: 8247522
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide producing neuroblastoma.
Cooney DR; Voorhess ML; Fisher JE; Brecher M; Karp MP; Jewett TC
J Pediatr Surg; 1982 Dec; 17(6):821-25. PubMed ID: 6298396
[TBL] [Abstract][Full Text] [Related]
19. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
[TBL] [Abstract][Full Text] [Related]
20. HCG-alpha and HCG-beta subunits as tumour markers during therapy in a case with so-called "non-functioning" islet cell tumour.
Oberg K; Wide L; Boström H
Acta Med Scand; 1981; 210(3):231-3. PubMed ID: 6270988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
